Results 211 to 220 of about 46,091 (305)

IgG4-Related Uveitis?

International audienceScope of work: IgG4-related ophthalmic disease manifests through several inflammatory conditions of the orbit, ocular adnexa, and intraocular compartment. Although a few cases of uveitis have been described in patients with IgG4-RD,
Hie, Miguel, Bencheikh, Saliha, Farhat, Meryem-Maud, Pugnet, Grégory, Urbina, Diego, de Sainte Marie, Benjamin, Schleinitz, Nicolas, Hatchuel, Yves, Ebbo, Mikael, Groh, Matthieu, Gerber, Anne, Stuchfield-Denby, Emily   +11 more
core  

Impact of Isolation Techniques on the Content of Small Extracellular Vesicles

Journal of Extracellular Vesicles, Volume 15, Issue 6, June 2026.
ABSTRACT An important topic of discussion amongst the extracellular vesicle (EV) research field is which genetic materials are considered true constituents of EV cargo. What were once regarded as non‐EV components have now evolved to be potentially essential to EV composition, serving as key mediators in communication.
Yue Su, Kekoolani S. Visan, Sarah Voss, Marta Prieto‐Vila, Juntaro Matsuzaki, Jason Ying Kuen Chan, Judy Wai Ping Yam, Andreas Möller   +7 more
wiley   +1 more source

Hearing the Unusual: A Rare Otological Case of IgG4-Related Disease Treated With Steroids and Inebiluzmab. [PDF]

ACR Open Rheumatol
Peng Y, Zaheer M.
europepmc   +1 more source

Broadly Protective Antibody‐Like Vaccines Against Highly Pathogenic Coronaviruses

Journal of Medical Virology, Volume 98, Issue 6, June 2026.
ABSTRACT SARS‐CoV‐2 and MERS‐CoV are highly pathogenic and contagious coronaviruses. Despite intensive vaccination, SARS‐CoV‐2 continues to spread, and no FDA‐approved vaccines exist for MERS‐CoV; thus, more effective and safer vaccine options are needed. The receptor‐binding domain (RBD) of coronaviruses is a primary target of neutralizing antibodies (
Assala Helal, Najwa D. Aljehani, Aishah Ghazwani, Reem M. Alsulaiman, Faris Alyami, Wesam H. Abdulaal, Asem Alsharef, Maimonah Alghanmi, Ayat Zawawi, Ala A. Azhari, Afnan Almehmadi, Jood Balula, Tarfa Altorki, Rowa Y. Alhabbab, Muhammad Yasir Khan, Khalid Alluhaybi, Aisha Alnami, Thikryat Neamatallah, Turki S. Abujamel, Mohamed A. Alfaleh, Anwar M. Hashem   +20 more
wiley   +1 more source

Isolated IgG4-related cholecystitis mimicking locally advanced gallbladder cancer: a case report. [PDF]

Korean J Clin Oncol
Noh BG, Seo HI, Park YM, Oh MH.
europepmc   +1 more source

Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria

JEADV Clinical Practice, Volume 5, Issue 2, Page 529-537, June 2026.
ABSTRACT Background Lebrikizumab is approved to treat patients with moderate‐to‐severe atopic dermatitis (AD). Objectives This study evaluated the 16‐week efficacy outcomes of lebrikizumab in adults and adolescents with severe AD in ADvocate trials who would be eligible for treatment based on South Korean reimbursement‐like criteria. Methods This was a
Chong Hyun Won, Chun Wook Park, Jiyoung Ahn, Joo Yeon Ko, Sang Hyun Cho, Yang Won Lee, Joo Hee Lee, Khai Jing Ng, Min Young Hong, Jinglin Zhong, Martin Dossenbach, Sang Wook Son   +11 more
wiley   +1 more source

Coexisting autoimmune pancreatitis and pancreatic adenocarcinoma: Diagnostic challenges and case insights. [PDF]

Radiol Case Rep
Qajia H, Jabbari C, Choumad S, Lejouad M, Eddahoumi Y, Nassar I, Imrani K.   +6 more
europepmc   +1 more source

Immunotherapy‐Related Cutaneous Toxicities in Melanoma: A Dermoscopic Perspective

JEADV Clinical Practice, Volume 5, Issue 2, Page 402-414, June 2026.
Dermoscopy serves as a valuable tool in the everyday dermatological and oncological practice for melanoma patients, allowing for the prompt identification of immune‐related cutaneous toxicities and guiding clinicians toward appropriate therapeutic decisions.
Grażyna Kamińska‐Winciorek, Iris Zalaudek, Karolina Zarańska, Bożena Cybulska‐Stopa   +3 more
wiley   +1 more source